SCHEMBL6710049

SCHEMBL6710049

Cn1c(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc2c(Br)cc(Br)c(NC(=O)Cc3ccccc3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.34
GPR35 Q9HC97 4/20 0.33
GALR3 O60755 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
ALDH1A1 P00352 3/20 0.32
GAA P10253 3/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712257 0.92 ALDH1A1 (0.36) KMT2AMEN1GALR3HTTRAB9A
SCHEMBL6713282 0.91 HIF1A (0.40) HIF1ANPSR1RXFP1KMT2AMEN1
SCHEMBL6707936 0.90 LMNA (0.35) KMT2AMEN1GALR3HTTRAB9A
SCHEMBL6710267 0.85 RXFP1 (0.34) HIF1ANPSR1RXFP1KMT2AMEN1
SCHEMBL6711947 0.85 GRIK1 (0.35) HIF1ANPSR1RXFP1KMT2AMEN1
SCHEMBL6710388 0.83 L3MBTL1 (0.38) KMT2AMEN1SMN1; SMN2CA1CA2
SCHEMBL6710370 0.82 HIF1A (0.38) HIF1ANPSR1RXFP1KMT2AGPR35
SCHEMBL6709946 0.81 LMNA (0.36) KMT2AMEN1GALR3HTTRAB9A
SCHEMBL6710280 0.79 HIF1A (0.38) HIF1ANPSR1RXFP1KMT2AGPR35
SCHEMBL6710212 0.78 GPR35 (0.35) HIF1ANPSR1RXFP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885NPSR1 2999/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.